Search

everythinglearnresearchcommunity

for

Search:↓

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Botulinum toxin shows promise for treating scalp sweating but not for hair growth.

Type 2 diabetes slows down skin and hair renewal by blocking important stem cell activation in mice.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

Hair follicles prevent NK cell attacks to avoid hair loss.

3D printed hollow microneedles could effectively treat skin wrinkles with fewer side effects.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Finasteride is more effective for hair loss in people with body hair.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Combining traditional Chinese medicine with microneedles shows promise for effectively treating skin diseases with fewer side effects.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

Hyaluronate fragments can help reverse skin thinning by working with the CD44 receptor.